$ENVX

Transcript: Enovix Corporation, Q2 2026 Earnings Call, Aug 12, 2026

Enovix Corporation held its Q2 2026 earnings conference call on Aug. 12, 2026. The transcript notes Enovix expects Q3 non-GAAP net loss per share of $0.17 to $0.13, compared with a FactSet estimate of a $0.14 loss.

Original reporting
Published Aug 13, 2026, 1:21 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 7:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$ENVX
Neutral
low confidence
Mentioned
$ENVX
Relevance
7/10
alphai data visualization · based on marketscreener.com
Decision brief

The 30-second read

$ENVXNeutralMed
01

Why it matters

The key actionable item is the Q3 non-GAAP net loss per share range, which sets expectations for profitability and can drive near-term repricing versus consensus.

02

Market read

Traders can benchmark the Q3 non-GAAP loss range against the FactSet estimate to gauge whether expectations are being reset.

03

What to watch

Without revenue, gross margin, cash balance, and burn-rate commentary, the EPS guidance alone may not capture the true risk to the equity story.

Relevance 7/10Novelty 6/10Timing: pre-market/after-hours positioning after the Aug 12 earnings call guidance

Background

This is a transcript listing for Enovix’s Q2 2026 earnings conference call, with an excerpted guidance line for Q3 non-GAAP EPS.

Company-level read

Ticker impact

$ENVXNeutralLow confidence
Context

Enovix’s Q2 2026 earnings call includes Q3 non-GAAP EPS guidance of a $0.17 to $0.13 loss versus a $0.14 loss estimate.

Expected impact

Near-term volatility likely around consensus comparison and whether the range is viewed as improving or worsening profitability trajectory.

Evidence & confidence

The excerpt provides only guidance numbers and no additional drivers (revenue, gross margin, cash burn, or segment updates), limiting conviction on direction.

Market effects

EV battery and energy-storage supply-chain sentiment may react to any read-through on Enovix’s profitability and funding needs, but details are missing here.

No clear regional spillover beyond US small/mid-cap growth sentiment.

Limited, as the excerpt does not include international demand, partnerships, or regulatory developments.

Counterpoint

The guidance range could be conservative, and traders may focus on any qualitative commentary (not shown) that signals improving operating leverage.

Key entities

  • Enovix Corporation

    Subject of the earnings call transcript; provides Q3 non-GAAP EPS guidance range.

Related articles

$ENVXHighAI 8/10

Why is Enovix stock plunging today?

Enovix (ENVX) shares fell 16.5% after the company said CEO Dr. Raj Talluri resigned effective Aug. 13, 2026. The board named CFO Ryan Benton interim CEO and chairman T.J. Rodgers executive chairman. An analyst downgraded the stock and removed its price target. Enovix reaffirmed Q3 2026 guidance and said Honor battery cells surpassed 1,000 charge cycles.

$ENVXMed

Enovix Corp (ENVX) (Q2 2026) Earnings Call Highlights: Smart Eyewear Ramp and Drone Pipeline Surge

Enovix (ENVX) reported Q2 2026 results on an earnings call. Smartphone qualification remains gated by a final accelerated hybrid cycle-life test expected by end-2026. Q2 revenue was $9M, up 21% YoY, with GAAP gross margin at 14% and non-GAAP at 18.9%. Smart Eyewear ramp is expected to keep margins negative through 2026, while drone/defense revenue conversion is not expected until mid-2027.

$ENVXMed

ENVX Stock Falls Overnight Despite Q2 Beat: Retail Bulls Shrug It Off As CEO Backs Smartphone, Wearables And Defense Demand

Enovix (ENVX) shares fell overnight after the company reported Q2 results that beat expectations but showed margin pressure. Enovix said Q2 revenue rose 21% to $9 million and EPS was a $0.20 loss. Gross margin was 14.4%. The company guided Q3 revenue of $9 million to $10 million and cited smartphone qualification progress, first smart-eyewear revenue, and a $183 million MX Platform pipeline.

$ENVXMedAI 8/10

Enovix Q2 Results: Adj. EPS beats estimate, sales up 21% YoY

Enovix (NASDAQ: ENVX) reported Q2 sales of $9.024M, up 20.84% YoY, beating the $8.430M consensus by 7.04%. Adjusted EPS was a loss of $(0.13), better than the $(0.15) estimate. For Q3, guidance calls for adjusted EPS of $(0.17) to $(0.13) and sales of $9.0M to $10.0M, both below consensus.